4 The Guideline Development Group, National Collaborating Centre and NICE project team

4.1 Guideline Development Group

Thomas Bourke
Consultant General Paediatrician, Royal Belfast Hospital for Sick Children

Kate Chadwick
Patient and carer member

Geoffrey John Crimmins
General Practitioner, Llantwit Major, Vale of Glamorgan

Steve Cunningham (Chair)
Consultant and Honorary Reader in Paediatric, Royal Hospital for Sick Children, Edinburgh

Julian Legg
Consultant in Paediatric Respiratory Medicine, Southampton Children's Hospital

Bhavee Mahesh Patel
Clinical Lead Paediatric Specialist Pharmacist, Morriston Hospital, Swansea

Clare van Miert
Clinical Nursing Research Fellow, Alder Hey Children's Hospital, Liverpool

Julie McKnight
Advanced Paediatric Nurse Practitioner, Royal Belfast Hospital for Sick Children

Debra Quantrill
Patient and carer member

Anshu Sharma
Paediatric Consultant, Russells Hall Hospital, Dudley

4.2 National Collaborating Centre for Women's and Children's Health

Zosia Beckles
Information Scientist

Anne Carty
Project Manager (from April 2014)

Jiri Chard
Senior Research Fellow and Guideline Lead (until August 2014)

Liz Bickerdike
Research Assistant (until September 2013)

Vanessa Delgado Nunes
Senior Research Fellow and Guideline Lead (from August 2014)

Stephen Murphy
Clinical Director for Children's Health

Katherine Cullen
Research Fellow – Health Economist (until January 2015)

Paul Jacklin
Senior Research Fellow – Health Economist (from December 2014)

Nitara Prasannan
Research Fellow (until October 2014)

Valentina Ricci
Research Fellow (from January 2014)

Gemma Marceniuk
Research Assistant (until May 2014)

Cristina Visintin
Project Manager (until April 2014)

4.3 NICE project team

Sarah Willett
Guideline Lead

Martin Allaby
Clinical Adviser

Oliver Bailey
Guideline Commissioning Manager (until February 2015)

Sarah Stephenson
Guideline Commissioning Manager (from February 2015)

Besma Nash
Guideline Coordinator

Judith Thornton
Technical Lead

David Glynn
Health Economist

Gareth Haman
Senior Medical Editor

4.4 Declarations of interests

The following members of the Guideline Committee made declarations of interests. All other members of the Committee stated that they had no interests to declare. The conflicts of interest policy (2007) was followed until September 2014, when an updated policy was published.

Member

Interest declared

Type of interest

Decision taken

Thomas Bourke

Expenses to attend a meeting from Novartis Pharmaceuticals (not related to bronchiolitis).

Personal pecuniary

Declare and participate

Thomas Bourke

Published a paper on bronchiolitis [Bourke T, Shields M (2011) Bronchiolitis. Clin Evid 04 (0308)].

Personal non‑pecuniary

Declare and participate

John Crimmins

Received an honorarium for an article on fever in children.

Personal financial non‑specific

Declare and participate

Steve Cunningham (Chair)

Advisory board attendance with honorarium for Gilead at which a product for cystic fibrosis was discussed, but also a brief discussion on a novel drug treatment for RSV bronchiolitis.

Personal non‑pecuniary

Declare and participate

Steve Cunningham (Chair)

Chief investigator in a project funded by HTA (BiDS) about oxygen saturation in infant with bronchiolitis at discharge from hospital.

Personal non‑pecuniary

Declare and participate

Steve Cunningham (Chair)

Principle Investigator for phase 1 study of novel drug treatment for RSV bronchiolitis in infants.

Personal non‑pecuniary

Declare and participate

Steve Cunningham (Chair)

Attends lunch meeting sponsored by GlaxoSmithKline every 3 months.

Personal pecuniary

Declare and participate

Steve Cunningham (Chair)

Consultancy work via NHS Lothian for Biotechnology company developing a novel drug treatment for RSV bronchiolitis in infants.

Personal pecuniary

Declare and participate

Julian Legg

Research interest in viral bronchiolitis.

Personal non‑pecuniary

Declare and participate

Julian Legg

Attended a medical meeting sponsored by GlaxoSmithKline at which a product unrelated to the current guideline was discussed. GlaxoSmithKline provided subsistence (a meal) for the attendees.

Personal pecuniary

Declare and participate

Julian Legg

Chaired meeting of Wessex Paediatric Respiratory Society in February 2014. This was an educational meeting sponsored by GlaxoSmithKline who arranged the venue and provided subsistence (a meal) for the attendees. No areas related to the current guideline were discussed.

Personal pecuniary

Declare and participate

Julian Legg

Attended a cystic fibrosis educational meeting (March 2015) organised by Forest Laboratories who provided overnight accommodation and subsistence (meals). No areas related to the current guideline were discussed.

Personal pecuniary

Declare and participate

Julian Legg

North American Cystic Fibrosis Conference 2015 – grant provided by Cystic Fibrosis Trust, UK for Conference Registration

Personal pecuniary

Declare and participate

Julian Legg

Expenses from Abbott Laboratories to support attendance of a meeting on Cystic Fibrosis organised by a charity (Child Health International) in Bulgaria in 2013.

Non‑personal pecuniary

Declare and participate

Clare van Miert

Clinical doctorate research fellowship funded by the National Institute for Health Research to Measuring Clinical Severity in Infants with Bronchiolitis.

Personal pecuniary

Declare and participate

Clare van Miert

Speaker at a respiratory meeting presenting doctorate research study

Personal non‑pecuniary

Declare and participate

Clare van Miert

Co‑applicant on a grant (PCORI) with aims to identify important outcomes for parents with children with acute respiratory infections

Personal non‑pecuniary

Declare and participate

Clare van Miert

Attended a preliminary meeting with representatives of Fisher & Paykel to explore the possibility that they would supply equipment and consumables for a research study investigating the efficacy and safety of high flow oxygen compared with standard care

Personal non‑pecuniary

Declare and participate

Clare van Miert

Published a paper [van Miert C, Abbott J, Verhoeff F, Lane S, Carter B, McNamara P (2014) Development and Validation of the Liverpool Infant Bronchiolitis Severity Score: a research protocol. Journal of Advanced Nursing]

Personal non‑pecuniary

Declare and participate

Clare van Miert

Submitted an application to HTA commission call for a feasibility study to look at the optimum thresholds for starting nCPAP and high‑flow oxygen in infants with bronchiolitis (£255,816.00)

Personal non‑pecuniary

Declare and participate

Clare van Miert

Attended a ground round meeting which had a breakfast sponsored by Spectrumthea (croissant and coffee)

Personal non‑pecuniary

Declare and participate

Clare van Miert

Co‑applicant for funding to Research for Patient Benefit on a bronchiolitis feasibility study

Personal financial specific

Declare and participate

Clare van Miert

Provided expert article on bronchiolitis: Bronchiolitis Nursing Standard, January 7 2015, vol 19 p 19.

Personal non‑financial specific

Declare and participate

Clare van Miert

Approached (via email) for information on parents 'needs' by a member of a parliamentary roundtable committee meeting for bronchiolitis after undertaking interviews with parents of infants with bronchiolitis as part PhD

Personal non‑financial specific

Declare and participate

Clare van Miert

Successfully applied for a travel bursary to present at RSV conference in South Africa (November 14) to present research on bronchiolitis but could not attend – PhD supervisor attended and presented the research

Non‑personal financial specific

Declare and participate

Debra Quantrill

Holds shares in Futura Medical plc – pharmaceutical group that develops products for the consumer healthcare market

Personal pecuniary

Declare and participate

  • National Institute for Health and Care Excellence (NICE)